# Neuralink Blindsight Vision-Restoration Implant Advances Toward First Human Trial

> clinical trial · REPORTED · 2026-01-29

Neuralink's Blindsight visual cortex implant, which carries FDA Breakthrough Device Designation and is designed to restore low-resolution vision by bypassing damaged eyes and optic nerves entirely, is advancing toward its first human implantation pending regulatory approval, with Elon Musk confirming on X that the company is ready to proceed as soon as clearance is granted.

About Neuralink: Neuralink develops implantable brain-computer interface devices targeting paralysis, speech restoration, and vision loss, with its Telepathy device already implanted in over a dozen patients and its Blindsight device aimed at fully blind individuals whose visual cortex remains intact.

- Company: Neuralink
- Sector: neurotech
- Primary source: https://www.thenews.com.pk/latest/1390244-neuralink-prepares-first-human-trials-of-blindsight-implant

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.